In a new study, the GLP-1 receptor agonist semaglutide was associated with greater weight loss than placebo -- and liraglutide.
The influenza virus can be debilitating for your diabetes patients for many reasons. Here are some tips to help you help them stay safe this year.
What's true and what's false about the connections between these often comorbid conditions? These 10 statements will test what you know.
A top-line look at the latest news: novel risk factors, insulin vs insulin; and predictors of weight loss success.
The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.
This screening model may improve retinopathy detection in patients with T1DM and decrease costs.
Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.
April news highlights the importance of timely eye examinations in young patients with diabetes and the efficacy of a teleretinal screening program.
Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.
When someone in the hospital needs to see a specialist, particularly a specialty where there are so few of us, I don’t understand how one can just refuse.